Cardiac complications in noncardiac surgery: relative value of resting two-dimensional echocardiography and dipyridamole thallium imaging.
Although perfusion imaging studies are extensively used as a preoperative screening test for risk stratification of patients undergoing noncardiac surgery, no single cardiac noninvasive test has been shown to be ideal for risk stratification. We investigated the relative impact of transthoracic two-dimensional echocardiography (ECHO) compared with dipyridamole thallium scintigraphy (DT) in predicting major cardiac complications in patients undergoing non-cardiac surgery. Eighty-seven consecutive patients undergoing 96 procedures (56 vascular, 40 general) underwent preoperative evaluation first with DT and then with ECHO before surgery. Complications were prospectively defined as myocardial infarction (MI), cardiac death (of MI, heart failure, or arrhythmia), or need of revascularization before surgery. DT showed one or more reversible defects in 44 (51%) patients, whereas ECHO demonstrated a reduced left ventricular ejection fraction (LVEF) in 25 (29%) patients. Major postoperative cardiac complications occurred in 10 patients: 5 deaths (2 ventricular fibrillation, 3 fatal MIs) and 5 nonfatal MIs. Four additional patients required urgent revascularization (coronary bypass graft surgery in 3 and percutaneous transluminal coronary angioplasty in 1). Of the 20 patients with both abnormal DT and ECHO, 11 (55%) had major complications, compared with none of the 26 (0%; p < 0.01) with an abnormal DT but normal LVEF. The sensitivity of DT and ECHO were not significantly different (79% [95% Cl, 52% to 93%] vs 86% [60% to 96%], respectively), although the specificity of DT was lower (51% [40% to 62%] vs 81% [70% to 88%]; p < 0.05). The positive predictive value of DT was significantly improved from 22% (12% to 35%) to 52% (32% to 72%) when both DT and ECHO were abnormal. The results were not significantly different when the 4 patients who underwent revascularization were excluded. In conclusion, (1) in spite of similar sensitivity of ECHO and DT, ECHO appears to be relatively more specific in predicting major CC, and (2) when ECHO and DT are both abnormal, the risk of CC related to noncardiac surgery is significantly increased. Use of the combination of DT and ECHO before major noncardiac surgery can improve the identification of patients at risk for complications.
Kontos
M C
MC
McGuire Veterans Affairs Medicine Center, Richmond, VA 23298, USA.
Brath
L K
LK
Akosah
K O
KO
Mohanty
P K
PK
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002303:Cardiac Output, Low / Q000209:etiology; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000150:complications* / Q000000981:diagnostic imaging; D016757:Death, Sudden, Cardiac / Q000209:etiology; D004176:Dipyridamole; D004452:Echocardiography; D005544:Forecasting; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D011183:Postoperative Complications; D011237:Predictive Value of Tests; D011300:Preoperative Care; D011446:Prospective Studies; D011877:Radionuclide Imaging; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013318:Stroke Volume; D013514:Surgical Procedures, Operative; D013794:Thallium Radioisotopes; D014656:Vascular Surgical Procedures; D014665:Vasodilator Agents; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging; D014693:Ventricular Fibrillation / Q000209:etiology
D013794:Thallium Radioisotopes; D014665:Vasodilator Agents; D004176:Dipyridamole